{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:28:34Z","timestamp":1793316514927,"version":"4.5.0"},"reference-count":53,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,11,2]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>ILT3 is ectopically expressed on mature CLL cells and CLL progenitors in the bone marrow. ILT3 controls the activation of Akt kinase in CLL and contributes to a regulatory network defined by a SHIP-1\/Deltex1 axis.<\/jats:p>","DOI":"10.1182\/blood-2017-03-775858","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T20:50:14Z","timestamp":1505940614000},"page":"2006-2017","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":21,"title":["Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia"],"prefix":"10.1182","volume":"130","author":[{"given":"Vanessa","family":"Zurli","sequence":"first","affiliation":[{"name":"Department of Life Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Wimmer","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cattaneo","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Candi","sequence":"additional","affiliation":[{"name":"Hematology Unit, University of Siena, Siena, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Cencini","sequence":"additional","affiliation":[{"name":"Hematology Unit, University of Siena, Siena, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gozzetti","sequence":"additional","affiliation":[{"name":"Hematology Unit, University of Siena, Siena, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Raspadori","sequence":"additional","affiliation":[{"name":"Hematology Unit, University of Siena, Siena, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Campoccia","sequence":"additional","affiliation":[{"name":"Department of Immune Hematology and Transfusion Medicine, University Hospital of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sanseviero","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3538-3913","authenticated-orcid":false,"given":"Monica","family":"Bocchia","sequence":"additional","affiliation":[{"name":"Hematology Unit, University of Siena, Siena, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4414-6744","authenticated-orcid":false,"given":"Cosima Tatiana","family":"Baldari","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2077-472X","authenticated-orcid":false,"given":"Anna","family":"Kabanova","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"21","key":"2019111903333264200_B1","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1200\/JCO.2003.02.134","article-title":"Binet\u2019s staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia","volume":"21","author":"Vasconcelos","year":"2003","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111903333264200_B2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc2764","article-title":"From pathogenesis to treatment of chronic lymphocytic leukaemia","volume":"10","author":"Zenz","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2019111903333264200_B3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.it.2013.07.002","article-title":"B cell receptor signaling in chronic lymphocytic leukemia","volume":"34","author":"Burger","year":"2013","journal-title":"Trends Immunol"},{"issue":"13","key":"2019111903333264200_B4","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/blood-2008-06-162024","article-title":"Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA","volume":"112","author":"Chu","year":"2008","journal-title":"Blood"},{"issue":"12","key":"2019111903333264200_B5","doi-asserted-by":"crossref","first-page":"e15992","DOI":"10.1371\/journal.pone.0015992","article-title":"Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells","volume":"5","author":"Binder","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"2019111903333264200_B6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1600-065X.2010.00936.x","article-title":"Molecular underpinning of B-cell anergy","volume":"237","author":"Yarkoni","year":"2010","journal-title":"Immunol Rev"},{"issue":"3","key":"2019111903333264200_B7","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","article-title":"Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia","volume":"101","author":"Lanham","year":"2003","journal-title":"Blood"},{"issue":"10","key":"2019111903333264200_B8","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","article-title":"Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status","volume":"109","author":"Mockridge","year":"2007","journal-title":"Blood"},{"issue":"9","key":"2019111903333264200_B9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2174\/092986710790712165","article-title":"The Bcl-2 family as a rational target for the treatment of B-cell chronic lymphocytic leukaemia","volume":"17","author":"Capitani","year":"2010","journal-title":"Curr Med Chem"},{"issue":"5","key":"2019111903333264200_B10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cell.2007.03.043","article-title":"Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia","volume":"129","author":"Raval","year":"2007","journal-title":"Cell"},{"issue":"3","key":"2019111903333264200_B11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10428190902763533","article-title":"Treatment resistance in chronic lymphocytic leukemia: the role of the p53 pathway","volume":"50","author":"Zenz","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"18","key":"2019111903333264200_B12","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1182\/blood-2009-08-239244","article-title":"Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia","volume":"115","author":"Capitani","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111903333264200_B13","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/MCB.24.4.1747-1757.2004","article-title":"p66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells","volume":"24","author":"Pacini","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2019111903333264200_B14","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1182\/blood-2007-12-130856","article-title":"The proapoptotic and antimitogenic protein p66SHC acts as a negative regulator of lymphocyte activation and autoimmunity","volume":"111","author":"Finetti","year":"2008","journal-title":"Blood"},{"key":"2019111903333264200_B15","doi-asserted-by":"crossref","first-page":"e1068","DOI":"10.1038\/cddis.2014.44","article-title":"Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc","volume":"5","author":"Patrussi","year":"2014","journal-title":"Cell Death Dis"},{"issue":"9","key":"2019111903333264200_B16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrm2240","article-title":"Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?","volume":"8","author":"Giorgio","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"2019111903333264200_B17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","article-title":"Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis","volume":"122","author":"Giorgio","year":"2005","journal-title":"Cell"},{"issue":"22","key":"2019111903333264200_B18","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1182\/blood-2012-04-425959","article-title":"S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis","volume":"120","author":"Capitani","year":"2012","journal-title":"Blood"},{"issue":"35","key":"2019111903333264200_B19","doi-asserted-by":"crossref","first-page":"57086","DOI":"10.18632\/oncotarget.10977","article-title":"Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells","volume":"7","author":"Cattaneo","year":"2016","journal-title":"Oncotarget"},{"issue":"W1","key":"2019111903333264200_B20","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2019111903333264200_B21","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.4049\/jimmunol.0902844","article-title":"SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells","volume":"184","author":"Brooks","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"2019111903333264200_B22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","article-title":"MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation","volume":"23","author":"Stacchini","year":"1999","journal-title":"Leuk Res"},{"issue":"10","key":"2019111903333264200_B23","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1084\/jem.185.10.1743","article-title":"A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing","volume":"185","author":"Cella","year":"1997","journal-title":"J Exp Med"},{"issue":"3","key":"2019111903333264200_B24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/ni760","article-title":"Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4","volume":"3","author":"Chang","year":"2002","journal-title":"Nat Immunol"},{"issue":"10","key":"2019111903333264200_B25","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1182\/blood-2005-05-2044","article-title":"Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3","volume":"106","author":"Penna","year":"2005","journal-title":"Blood"},{"issue":"12","key":"2019111903333264200_B26","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"issue":"2","key":"2019111903333264200_B27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","article-title":"Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia","volume":"20","author":"Kikushige","year":"2011","journal-title":"Cancer Cell"},{"issue":"1","key":"2019111903333264200_B28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.immuni.2009.04.017","article-title":"Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy","volume":"31","author":"Hsiao","year":"2009","journal-title":"Immunity"},{"key":"2019111903333264200_B29","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1038\/ncomms7353","article-title":"Deltex1 antagonizes HIF-1\u03b1 and sustains the stability of regulatory T cells in vivo","volume":"6","author":"Hsiao","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"2019111903333264200_B30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2005.01162.x","article-title":"Regulation of ILT3 gene expression by processing of precursor transcripts in human endothelial cells","volume":"6","author":"Kim-Schulze","year":"2006","journal-title":"Am J Transplant"},{"issue":"4","key":"2019111903333264200_B31","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/MCB.25.4.1367-1378.2005","article-title":"Deltex regulates T-cell activation by targeted degradation of active MEKK1","volume":"25","author":"Liu","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"7","key":"2019111903333264200_B32","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3324\/haematol.2013.098384","article-title":"The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy","volume":"99","author":"Packham","year":"2014","journal-title":"Haematologica"},{"issue":"7","key":"2019111903333264200_B33","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cellsig.2009.03.007","article-title":"Phosphorylation of the activation loop tyrosines is required for sustained Syk signaling and growth factor-independent B-cell proliferation","volume":"21","author":"Carsetti","year":"2009","journal-title":"Cell Signal"},{"issue":"12","key":"2019111903333264200_B34","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1182\/blood-2004-07-2669","article-title":"Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells","volume":"105","author":"Petlickovski","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111903333264200_B35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1182\/blood-2007-05-089037","article-title":"The Akt\/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells","volume":"111","author":"Longo","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111903333264200_B36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.leu.2404417","article-title":"The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease","volume":"21","author":"Longo","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"2019111903333264200_B37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/leu.2014.158","article-title":"Activation of the PI3K\/AKT pathway by microRNA-22 results in CLL B-cell proliferation","volume":"29","author":"Palacios","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"2019111903333264200_B38","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2010.46","article-title":"CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation","volume":"24","author":"Efanov","year":"2010","journal-title":"Leukemia"},{"key":"2019111903333264200_B39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fimmu.2012.00228","article-title":"Akt and mTOR in B cell activation and differentiation","volume":"3","author":"Limon","year":"2012","journal-title":"Front Immunol"},{"issue":"5","key":"2019111903333264200_B40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.20150537","article-title":"Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells","volume":"213","author":"Getahun","year":"2016","journal-title":"J Exp Med"},{"issue":"4","key":"2019111903333264200_B41","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2008.346","article-title":"Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells","volume":"23","author":"Gobessi","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"2019111903333264200_B42","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood-2006-03-011759","article-title":"ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells","volume":"109","author":"Gobessi","year":"2007","journal-title":"Blood"},{"issue":"7","key":"2019111903333264200_B43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/intimm\/dxv009","article-title":"Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals","volume":"27","author":"Inui","year":"2015","journal-title":"Int Immunol"},{"issue":"2","key":"2019111903333264200_B44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2249.2010.04206.x","article-title":"Reference values for B cell subpopulations from infancy to adulthood","volume":"162","author":"Morbach","year":"2010","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"2019111903333264200_B45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cyto.b.20164","article-title":"Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia","volume":"72B","author":"Colovai","year":"2007","journal-title":"Cytometry B Clin. Cytom"},{"issue":"2","key":"2019111903333264200_B46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.coi.2011.01.001","article-title":"Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation","volume":"23","author":"Baracho","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"26","key":"2019111903333264200_B47","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1182\/blood-2012-01-403162","article-title":"Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT","volume":"119","author":"Negro","year":"2012","journal-title":"Blood"},{"issue":"11","key":"2019111903333264200_B48","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1084\/jem.20091962","article-title":"Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases","volume":"207","author":"Miletic","year":"2010","journal-title":"J Exp Med"},{"issue":"1","key":"2019111903333264200_B49","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","article-title":"Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy","volume":"112","author":"Muzio","year":"2008","journal-title":"Blood"},{"issue":"19","key":"2019111903333264200_B50","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood-2012-12-474718","article-title":"Targeting B-cell anergy in chronic lymphocytic leukemia","volume":"121","author":"Apollonio","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2019111903333264200_B51","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.immuni.2011.10.011","article-title":"Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy","volume":"35","author":"O\u2019Neill","year":"2011","journal-title":"Immunity"},{"issue":"9","key":"2019111903333264200_B52","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood.V97.9.2777","article-title":"Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia","volume":"97","author":"Granziero","year":"2001","journal-title":"Blood"},{"issue":"10","key":"2019111903333264200_B53","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","article-title":"CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment","volume":"111","author":"Patten","year":"2008","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/18\/2006\/1403561\/blood775858.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/130\/18\/2006\/1403561\/blood775858.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:34:10Z","timestamp":1574134450000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/130\/18\/2006\/36542\/Ectopic-ILT3-controls-BCRdependent-activation-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,2]]},"references-count":53,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,11,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-03-775858","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,2]]}}}